Kerry aims to acquire part of Chr. Hansen and Novozymes’ lactase enzyme business
The acquisition would give Kerry additional technology to create lactose-free and reduced-sugar dairy products.
Kerry Group plc (Tralee, Ireland) announced plans to acquire part of the global lactase enzyme business belonging to Chr. Hansen Holding A/S and Novozymes A/S.
“The acquisition is subject to European Commission approval of Kerry as a buyer and forms part of the Novozymes and Chr. Hansen merger-approval process,” Kerry’s press release notes.
The acquisition would boost Kerry’s enzyme technology to create lactose-free and reduced-sugar dairy products, the firm says. Kerry had already acquired enzyme manufacturers c-LEcta and Enmex. This latest acquisition would further bolster the company’s biotechnology capabilities.
Gencor to distribute Gnosis by Lesaffre’s Landkind Pure Salidroside in the United States
September 11th 2024The ingredient is manufactured by Gnosis by Lesaffre as an alternative to rhodiola extract. Salidroside is the most studied bioactive in rhodiola, to which the extract efficacy is attributed to.
New review from BAPP estimates adulteration of five popular botanicals
September 10th 2024The study focused on the adulteration of black cohosh rhizome, echinacea root or herb, elder berry, ginkgo leaf, and turmeric root/rhizome. The authors reviewed 78 publications with a total of 2995 samples. Of the 2995 samples, 818 were reported to be adulterated or mislabeled.
